In this study, a prospective randomized controlled trial was conducted to measure the molecular markers (mRNA expression of ERCC1, RRM1, and TUBB3) in tumour tissue specimens from patients who needed adjuvant chemotherapy after surgery. The gene discussed is ERCC1; the disease is neoplasm.